People with lupus have a higher risk of hearing loss due to inflammation that can damage the inner ear and auditory pathways. Hearing loss is a lesser-known complication of lupus, but it can ...

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

HCQ is recommended for all patients with lupus at a target dose 5 mg/kg real body weight/day, considering the individual’s risk for flares and retinal toxicity. GC are used as ‘bridging therapy’ ...